Description: Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and government authorities and academic institutions, as well as clinical, forensic, and academic laboratories. It operates in 70 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.
Home Page: www.biotage.com
Box 8
Uppsala,
751 03
Sweden
Phone:
46 18 56 59 00
Officers
Name | Title |
---|---|
Mr. Tomas Blomquist | CEO & Pres |
Ms. Maja Nilsson | Chief Financial Officer |
Mr. Anders Wikstrom BSc, CS | Exec. VP of Operations |
Dr. Jon-Sverre Schanche Ph.D. | Chief Scientific Officer |
Mr. Lars Backman LLB | Chief Legal Officer |
Raffaella Bombarda | EVP of Global Marketing |
Ms. Petra Duprez | Chief HR & Sustainability Officer |
Mr. Scott Carr | Pres of Americas & Chief/Head of Americas |
Mr. Jonas Stahlberg | Chief Auditor |
Mr. Olof Nord | Exec. VP of Bus. Devel. |
Exchange: ST
Country: SE
Currency: Swedish krone (kr)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Life Sciences Tools & Services |
GIC Sub-Industry: | Life Sciences Tools & Services |
Forward PE: | 0 |
---|---|
Trailing PE: | 50.0567 |
Price-to-Book MRQ: | 8.1191 |
Price-to-Sales TTM: | 8.0358 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 510 |